Find clinical trials for Incyte. Search for Incyte clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 32
New
A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants
for
Healthy Participants
Location: Dilworth MN
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 65
Code: NCT07588139
Phase1, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Montreal, Toronto
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05936359
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
for
Prurigo Nodularis
Location: Quebec, Stony Brook NY, New York NY, Verdun,
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 70+
Code: NCT06516952
Phase3, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase1, Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Chattanooga TN, Billings MT, Los Angeles CA
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
for
Solid Tumors, Hematologic Malignancies
Location: Nashville TN, Houston TX, Duarte CA
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07195916
Phase1, Recruiting
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: New Haven CT, New York NY, Montreal, Philadelphia PA,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06388564
Phase2, Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,